Our findings contrast those of a smaller non-randomised pilot study in treatment-naïve CLL which reported 21.4% less disease outgrowth of CD5+/CD19+ B-CLL cells in an exercise group compared with a control group following 12 weeks of HIIT (12). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.